IDEXX Laboratories (IDXX)
(Real Time Quote from BATS)
$392.03 USD
-4.40 (-1.11%)
Updated Aug 15, 2022 11:52 AM ET
4-Sell of 5 4
D Value C Growth C Momentum D VGM
Detailed Estimates
Estimates
Exp Earnings Date | 11/1/22 |
---|---|
Current Quarter | 2.04 |
EPS Last Quarter | 1.56 |
Last EPS Surprise | 1.30% |
ABR | 1.65 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 7.91 |
Next Year | 9.61 |
EPS (TTM) | 7.75 |
P/E (F1) | 50.14 |
Sales Estimates
Current Qtr (9/2022) |
Next Qtr (12/2022) |
Current Year (12/2022) |
Next Year (12/2023) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 837.32M | 837.23M | 3.37B | 3.66B |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 863.97M | 868.25M | 3.43B | 3.76B |
Low Estimate | 825.93M | 824.70M | 3.35B | 3.60B |
Year ago Sales | 810.42M | 801.09M | 3.22B | 3.37B |
Year over Year Growth Est. | 3.32% | 4.51% | 4.85% | 8.53% |
Earnings Estimates
Current Qtr (9/2022) |
Next Qtr (12/2022) |
Current Year (12/2022) |
Next Year (12/2023) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.04 | 2.03 | 7.91 | 9.61 |
# of Estimates | 7 | 6 | 6 | 7 |
Most Recent Consensus | 2.08 | 2.01 | 7.91 | 9.47 |
High Estimate | 2.08 | 2.08 | 7.95 | 9.94 |
Low Estimate | 2.02 | 1.95 | 7.85 | 9.12 |
Year ago EPS | 2.03 | 1.89 | 8.60 | 7.91 |
Year over Year Growth Est. | 0.49% | 7.41% | -8.02% | 21.53% |
Agreement - Estimate Revisions
Current Qtr (9/2022) |
Next Qtr (12/2022) |
Current Year (12/2022) |
Next Year (12/2023) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 2 | 2 | 1 | 2 |
Down Last 30 Days | 6 | 6 | 6 | 7 |
Down Last 60 Days | 5 | 5 | 6 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2022) |
Next Qtr (12/2022) |
Current Year (12/2022) |
Next Year (12/2023) |
|
---|---|---|---|---|
Current | 2.04 | 2.03 | 7.91 | 9.61 |
7 Days Ago | 2.07 | 2.08 | 7.92 | 9.74 |
30 Days Ago | 2.27 | 2.15 | 8.23 | 10.35 |
60 Days Ago | 2.27 | 2.15 | 8.24 | 10.33 |
90 Days Ago | 2.27 | 2.15 | 8.24 | 10.33 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2022) |
Next Qtr (12/2022) |
Current Year (12/2022) |
Next Year (12/2023) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.04 | 2.03 | 7.91 | 9.61 |
Zacks Consensus Estimate | 2.04 | 2.03 | 7.91 | 9.61 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2022) |
Quarter Ending (3/2022) |
Quarter Ending (12/2021) |
Quarter Ending (9/2021) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.56 | 2.27 | 1.89 | 2.03 | NA |
Estimate | 1.54 | 2.25 | 1.67 | 1.88 | NA |
Difference | 0.02 | 0.02 | 0.22 | 0.15 | 0.10 |
Surprise | 1.30% | 0.89% | 13.17% | 7.98% | 5.84% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more